KTTAW vs SNPS
Pasithea Therapeutics Corp. Warrant (KTTAW) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US. It is led by Sassine Ghazi.
KTTAW does not have a complete income-statement cache yet.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
KTTAW currently screens at market cap $0. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the KTTAW and SNPS stock pages for the full models.
Not investment advice.